VelsafeVelsafe

Workplace Safety Guides, Insights & Training

Velocity Safe Blog
  • Sign in /
  • join
  • Home
  • Insights
  • Guides
  • Practice Tests
  • Tips
  • Worker Safety
  • Situational
  • OSHA Tools
  • Law

Home » Clinical: Pharmaceutical

Clinical: Pharmaceutical

Male clinical researcher in white lab coat using a pipette with blood specimen tubes and microscope on a lab bench
August 18, 2026
by VelSafe Editorial Team Law

Clinical Research Specimens: FDA and CLIA Obligations

Read More
Pharmaceutical scientist in PPE working with investigational product samples in a GMP laboratory, representing IND, CMC, and clinical manufacturing compliance
August 11, 2026
by VelSafe Editorial Team Insights

Investigational Product Development: IND, CMC, GMP

Read More
10 informed consent tips featured image showing a healthcare professional holding an Informed Consent clipboard listing purpose and procedure, risks and benefits, alternatives, confidentiality, and right to withdraw, with a callout stating good information leads to better decisions and ethical care starts with informed choices.
August 6, 2026
by VelSafe Editorial Team Tips

10 Informed Consent Tips for Healthcare Professionals

TIPS: Informed Consent 10 Informed Consent Tips Every Healthcare and Research Professional Needs to Know Informed consent is not a signature on a form. It is an ongoing process of communication that ensures the person giving consent genuinely

Read More
HIPAA impact on clinical research featured image showing a clinical research coordinator pointing at a whiteboard with an IRB and consent flowchart, with a horizontal bar chart comparing HIPAA risk levels across different research data types in a split diagonal overlay panel.
July 30, 2026
by VelSafe Editorial Team Tips

HIPAA: The Impact on Clinical Research

TIPS: HIPAA and Clinical Research HIPAA in Clinical Research: 10 Practical Tips for Research Professionals Clinical research involves collecting and disclosing PHI in ways that fall outside standard treatment and payment activities. HIPAA's P

Read More
GxP framework guide showing GMP GLP GCP GDP and GPvP good practice regulations mapped across the pharmaceutical and medical device product lifecycle
July 10, 2026
by VelSafe Editorial Team Guides

GxPs: A Complete Guide to Good Practice Frameworks Across the Product Lifecycle

Read More
GCP worker safety guide for clinical trial site staff covering participant safety, informed consent, documentation and ICH E6(R3) training requirements
July 9, 2026
by VelSafe Editorial Team Worker Safety

Good Clinical Practices for Clinical Trial Site Staff: What Every Worker Needs to Know

Read More
GCP ICH E6(R3) compliance infographic showing 12 tips for sponsors, monitors, and investigators covering consent, delegation, safety reporting, and TMF management
July 2, 2026
by VelSafe Editorial Team Tips

GCP/ICH Obligations: 12 Tips for Site Teams

ICH E6(R3) — effective July 2025 under EMA and published by FDA in September 2025 — is the most significant update to Good Clinical Practice in nearly three decades. While the guideline introduces a risk-proportionate, Quality by Design framework,

Read More
gcp-ich-sponsors-monitors-practice-test
July 2, 2026
by VelSafe Editorial Team Practice Tests

GCP/ICH Sponsors and Monitors: 15 Practice Questions

Under ICH E6(R3), the sponsor is the entity that takes ultimate responsibility for the initiation, management, and financing of a clinical trial. The monitor is the sponsor's representative at the site, responsible for verifying that the trial is

Read More
gcp-ich-obligations-investigators
July 2, 2026
by VelSafe Editorial Team Guides

GCP/ICH Obligations of Investigators: Complete Guide

The principal investigator is the individual responsible for the conduct of a clinical trial at a site. Under ICH E6(R3) — the Good Clinical Practice guideline that came into effect on 23 July 2025 — the investigator's obligations span every phase

Read More
financial-disclosure-ci
June 19, 2026
by VelSafe Editorial Team Guides

Financial Disclosure by Clinical Investigators Guide

When a sponsor submits a marketing application to the FDA, the agency does not evaluate the clinical data in isolation. It considers who conducted the studies and whether any financial relationships between those investigators and the sponsor coul

Read More
  • 1
  • 2
  • Next
  • Last

Subscribe Now

VelSafe Subscribe
VelsafeVelsafe

Workplace Safety Guides, Insights & Training

Linkedin Twitter Instagram
Category
  • Insights
  • Guides
  • TIPS
  • LAW
  • Practice Tests
  • SITUATIONAL
Info
  • About Us
  • Get Featured
  • Newsletter
  • Contact Us
Popular Posts
Medicare Advantage provider compliance law 42 CFR Part 422 showing network adequacy credentialing prompt payment participation rules and anti-discrimination requirements
September 5, 2026

Medicare Advantage Provider Compliance: The Law

Medicare Advantage Part C and Part D grievances law compliance binders and grievance process checklist
September 4, 2026

Medicare Advantage Grievances: Part C and…

Newsletter

Send us a newsletter to get update


    © 2026 . All rights reserved.
    Shopping Basket